Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker FTAI
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | David Moreno President | FTAI FTAI Aviation Ltd. | Buy | 2,475 | $201.27 | $498.1K Buy | Form 4 ↗ |
| May 27, 2026 | Judith A. Hannaway Director | FTAI FTAI Aviation Ltd. | Sale | 255 | $253.89 | $64.7K Sale | Form 4 ↗ |
| May 4, 2026 | Martin Tuchman Director | FTAI FTAI Aviation Ltd. | Sale | 67,500 | $241.99 | $16.3M Sale | Form 4 ↗ |
| May 4, 2026 | Martin Tuchman Director | FTAI FTAI Aviation Ltd. | Sale | 43,176 | $240.64 | $10.4M Sale | Form 4 ↗ |
| May 1, 2026 | Martin Tuchman Director | FTAI FTAI Aviation Ltd. | Sale | 143,584 | $242.44 | $34.8M Sale | Form 4 ↗ |
| Feb 27, 2026 | Paul R. Goodwin Director | FTAI FTAI Aviation Ltd. | Sale | 10,000 | $303.35 | $3.0M Sale | Form 4 ↗ |
| Nov 14, 2025 | Eun Nam Chief Financial Officer | FTAI FTAI Aviation Ltd. | Buy | 652 | $153.46 | $100.1K Buy | Form 4 ↗ |
| Nov 13, 2025 | David Moreno Chief Operating Officer | FTAI FTAI Aviation Ltd. | Buy | 4,354 | $153.89 | $670.0K Buy | Form 4 ↗ |
| Nov 13, 2025 | David Moreno Chief Operating Officer | FTAI FTAI Aviation Ltd. | Buy | 2,283 | $153.50 | $350.4K Buy | Form 4 ↗ |
| Nov 13, 2025 | Joseph P. Adams Jr. CEO and Chairman, Director | FTAI FTAI Aviation Ltd. | Buy | 2,000 | $155.91 | $311.8K Buy | Form 4 ↗ |
| May 5, 2025 | Martin Tuchman Director | FTAI FTAI Aviation Ltd. | Buy | 1,000 | $99.19 | $99.2K Buy | Form 4 ↗ |
| May 2, 2025 | Stacy Kuperus Chief Portfolio Officer | FTAI FTAI Aviation Ltd. | Buy | 1,087 | $92.90 | $101.0K Buy | Form 4 ↗ |
| May 2, 2025 | David Moreno Chief Operating Officer | FTAI FTAI Aviation Ltd. | Buy | 6,580 | $94.85 | $624.1K Buy | Form 4 ↗ |
| May 2, 2025 | Joseph P. Adams Jr. CEO and Chairman, Director | FTAI FTAI Aviation Ltd. | Buy | 3,000 | $94.54 | $283.6K Buy | Form 4 ↗ |
| Feb 28, 2025 | Martin Tuchman Director | FTAI FTAI Aviation Ltd. | Buy | 2,200 | $128.79 | $283.3K Buy | Form 4 ↗ |
| Nov 22, 2024 | Paul R. Goodwin Director | FTAI FTAI Aviation Ltd. | Sale | 20,000 | $174.36 | $3.5M Sale | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:20 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances